NDTVCenter·
AstraZeneca Pharma Gets CDSCO Nod To Sell Enhertu For Breast Cancer
AstraZeneca Pharma India received approval from the CDSCO to import and sell Enhertu for an additional HER2 positive breast cancer indication in India.
Read at NDTV →
Business · 1 sources covering this
AstraZeneca Pharma Gets CDSCO Nod To Sell Enhertu For Breast Cancer
AstraZeneca Pharma India received approval from the CDSCO to import and sell Enhertu for an additional HER2 positive breast cancer indication in India.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://hindustansphere.com/embed/cluster/ace85f2293abd641eb998cf1fad1ac47a15cfd06" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="AstraZeneca Pharma Gets CDSCO Nod To Sell Enhertu For Breast Cancer"></iframe>
